Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II study.
Palmeri S, Vaglica M, Spada S, Filippelli G, Farris A, Palmeri L, Massidda B, Misino A, Ferraù F, Comella G, Leonardi V, Condemi G, Mangiameli A, De Cataldis G, Macaluso MC, Cajozzo M, Iannitto E, Danova M. Palmeri S, et al. Among authors: vaglica m. Oncology. 2005;68(4-6):438-45. doi: 10.1159/000086986. Epub 2005 Jul 14. Oncology. 2005. PMID: 16020974 Free article. Review.
Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : results of an Italian multicenter, randomized, phase II study.
Palmeri S, Lorusso V, Palmeri L, Vaglica M, Porta C, Nortilli R, Ferraú F, Comella G, Massidda B, Danova M; Carcinomas of Unknown Primary Italian Study Group. Palmeri S, et al. Among authors: vaglica m. Cancer. 2006 Dec 15;107(12):2898-905. doi: 10.1002/cncr.22379. Cancer. 2006. PMID: 17109447 Free article. Clinical Trial.
Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial.
Palmeri S, Leonardi V, Gebbia V, De Bella MT, Ferraù F, Faillú G, Spatafora M, Valenza R, Di Vita G, Vitello S, Carroccio R, Sciortino G, Vaglica M, Accurso V, Agostara B, Licata G. Palmeri S, et al. Among authors: vaglica m. Lung Cancer. 2001 Oct;34(1):115-23. doi: 10.1016/s0169-5002(01)00206-9. Lung Cancer. 2001. PMID: 11557121 Clinical Trial.
Cytokine gene polymorphisms and breast cancer susceptibility.
Scola L, Vaglica M, Crivello A, Palmeri L, Forte GI, Macaluso MC, Giacalone A, Di Noto L, Bongiovanni A, Raimondi C, Accardo A, Verna R, Candore G, Caruso C, Lio D, Palmeri S. Scola L, et al. Among authors: vaglica m. Ann N Y Acad Sci. 2006 Nov;1089:104-9. doi: 10.1196/annals.1386.017. Ann N Y Acad Sci. 2006. PMID: 17261759
Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma.
Crivello A, Giacalone A, Vaglica M, Scola L, Forte GI, Macaluso MC, Raimondi C, Di Noto L, Bongiovanni A, Accardo A, Candore G, Palmeri L, Verna R, Caruso C, Lio D, Palmeri S. Crivello A, et al. Among authors: vaglica m. Ann N Y Acad Sci. 2006 Nov;1089:98-103. doi: 10.1196/annals.1386.002. Ann N Y Acad Sci. 2006. PMID: 17261758
20 results